LDS/Medical Tests/Tumor Necrosis Factor Alpha (TNF-α)

Tumor Necrosis Factor Alpha (TNF-α)

Tumor necrosis factor alpha (TNF-α), also known as cachectin and TNFSF1A, is the prototypic ligand of the TNF superfamily. It is a pleiotropic molecule that plays a central role in inflammation, apoptosis, and immune system development. TNF-α is produced by a wide variety of immune and epithelial cell types. Human TNF-α consists of a 35 amino acid (aa) cytoplasmic domain, a 21 aa transmembrane segment, and a 177 aa extracellular domain (ECD). The 26 kDa type 2 transmembrane protein is assembled intracellularly to form a noncovalently linked homotrimer. Ligation of this complex induces reverse signaling that promotes lymphocyte costimulation but diminishes monocyte responsiveness. TNF-α regulates lymphoid tissue development through control of apoptosis. It also promotes inflammatory responses by inducing the activation of vascular endothelial cells and macrophages.

TNF-α is a key cytokine in the development of several inflammatory disorders. It contributes to the development of type 2 diabetes through its effects on insulin resistance and fatty acid metabolism. TNF-α is also implicated in the development of inflammatory bowel diseases including ulcerative colitis and Crohn’s disease. In the tracheobronchial tissue, administration of TNF-α has shown to activate mast cells to release cysteinyl-leukotrienes LTC4 and LTD4 which are potent bronchoconstrictors and mediators of airway hyperresponsiveness, as in asthma. Clinical trials of TNF-α inhibitors have yielded promising results in the treatment of chronic inflammatory disorders such as rheumatoid arthritis, asthma, ulcerative colitis and Crohn’s disease.

  • As an aid in diagnosis of inflammatory diseases and inflammation responses
  • As an aid in diagnosis and management of type 2 diabetes
  • As an aid in diagnosis and management of inflammatory bowel diseases
  • As an aid in diagnosis and management of ulcerative colitis and Crohn’s disease
  • As an ancillary test for asthma and asthma treatment
  • As a marker for management of rheumatoid arthritis therapy
  • It can serve to monitor infection and treatment 
Positive results or increased levels of TNF alpha might indicate inflammation and inflammatory reaction. Results must be used with other markers and should be correlated with clinical findings.

0-22 pg/mL

 

 

Enzyme-linked Immunosorbent Assay (ELISA) and other immunoassays for semiquantitative detection of anti-TNF alpha antibody.

Serum collected in SST tubes, plain red, or plasma collected in green (lithium heparin).

Specimens should be frozen after serum/plasma separation (after 30 minutes).

Interleukin Beta-1, CRP, Sed rate, albumin, liver panel, alpha-1-antitrypsin, bacterial culture, haptoglobin, Rheumatoid Factor, fibrinogen, Complement components C3, C4, Interferon gamma receptor1 and 2, other cytokines, Acute hepatitis panel.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login